title: Morbidity and mortality in hemodialysis patients with and without erythropoietin treatment: a controlled study.
authors.affiliation: Abteilung Nephrologie, Medizinische Hochschule, Hannover, FRG.
authors.forename: J
authors.initials: J
authors.lastname: Bahlmann
authors.forename: K H
authors.initials: KH
authors.lastname: Schöter
authors.forename: P
authors.initials: P
authors.lastname: Scigalla
authors.forename: H J
authors.initials: HJ
authors.lastname: Gurland
authors.forename: M
authors.initials: M
authors.lastname: Hilfenhaus
authors.forename: K M
authors.initials: KM
authors.lastname: Koch
authors.forename: F A
authors.initials: FA
authors.lastname: Muthny
authors.forename: H H
authors.initials: HH
authors.lastname: Neumayer
authors.forename: W
authors.initials: W
authors.lastname: Pommer
authors.forename: E
authors.initials: E
authors.lastname: Quelhorst
mesh_terms: D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006973:Hypertension / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects* / Q000401:mortality
chemical_list: D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin